Abstract
Topical 0.03% tacrolimus was used for treatment of a Korea Jindo dog diagnosed with pemphigus erythematosus. The dog was slowly improved following application of tacrolimus but did not achieve complete remission until end of this study. No adverse effects on clinical or laboratory parameters were noted during the topical tacrolimus therapy period.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 415-417 |
| Number of pages | 3 |
| Journal | Journal of Veterinary Medical Science |
| Volume | 70 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 1 2008 |
| Externally published | Yes |
Keywords
- Canine
- Pemphigus erythematosus
- Topical 0.03% tacrolimus
ASJC Scopus subject areas
- veterinary(all)
Fingerprint Dive into the research topics of 'Topical 0.03% tacrolimus for treatment of pemphigus erythematosus in a Korea Jindo dog'. Together they form a unique fingerprint.
Cite this
Bhang, D. H., Choi, U. S., Jung, Y. C., Kim, M. K., Choi, E. W., Seo, K. W., Kang, M. S., Hwang, C. Y., Kim, D. Y., Youn, H. Y., & Lee, C. W. (2008). Topical 0.03% tacrolimus for treatment of pemphigus erythematosus in a Korea Jindo dog. Journal of Veterinary Medical Science, 70(4), 415-417. https://doi.org/10.1292/jvms.70.415